Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Grant or award EVP, Chief Financial Officer acquired 11,534 shares (grant or award)
  2. 4 Shares withheld for taxes EVP, Chief HR Officer gave up 237 shares (to pay taxes)
  3. 4 Grant or award President and COO acquired 1,293 shares (grant or award)
  4. 4 Open-market sale Director sold 7,893 shares at $55.00 ($434,115)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Shares withheld for taxes Chairman gave up 3,224 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, Administration and CFO gave up 1,727 shares (to pay taxes)
  8. 4 Open-market sale EVP, Business Operations sold 5,842 shares at $52.82 ($308,574)
  9. 4 Shares withheld for taxes President & CEO gave up 7,825 shares (to pay taxes)
  10. 4 Exercise or conversion EVP, Business Operations acquired 6,573 shares (option exercise)
  11. 4 Shares withheld for taxes Chairman gave up 4,753 shares (to pay taxes)
  12. 4 Grant or award EVP, Corp Dev, GC & Secretary acquired 10,626 shares (grant or award)
  13. 4 Shares withheld for taxes EVP, Chief HR Officer gave up 927 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, Administration and CFO gave up 2,323 shares (to pay taxes)
  15. 4 Open-market sale EVP, Business Operations sold 1,898 shares at $49.50 ($93,951)
  16. 4 Shares withheld for taxes President & CEO gave up 9,923 shares (to pay taxes)
  17. 4 Open-market sale Director sold 7,729 shares at an average $50.69 ($391,787)
  18. 4 Open-market sale President & CEO sold 21,906 shares at $47.91 ($1,049,516)
  19. 4 Open-market sale President & CEO sold 20,000 shares at $45.99 ($919,800)
  20. 4 Open-market sale Director sold 23,681 shares at $45.02 ($1,066,225)

Page 20 of 49 · 970 filings